Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.
暂无分享,去创建一个
N. Sattar | H. Heerspink | K. Duffin | K. Tuttle | I. Pávó | A. Haupt | D. Cherney | Hiddo J L Heerspink | Naveed Sattar | Imre Pavo | Axel Haupt | Kevin L Duffin | Zhengyu Yang | Russell J Wiese | Katherine R Tuttle | David Z I Cherney | R. Wiese | Zhengyu Yang